BRIEF-PainReform Confirms Sutures Compatibility In Human Clinical Trials For PRF-110

Reuters09-11

Sept 11 (Reuters) - PainReform Ltd :

* PAINREFORM LTD. CONFIRMS SUTURES COMPATIBILITY IN HUMAN CLINICAL TRIALS FOR PRF-110

* PAINREFORM LTD - PRF-110 DOES NOT IMPACT MECHANICAL PROPERTIES OF PROLENE OR VICRYL SUTURES

* PAINREFORM LTD - FINDINGS CONSISTENT WITH PHASE III BUNIONECTOMY TRIAL RESULTS

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2466235957?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-11 23:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2466235957","market":"us","top_or_hot":-1,"title":"BRIEF-PainReform Confirms Sutures Compatibility In Human Clinical Trials For PRF-110","media":"Reuters","content":"<html><body><p>Sept 11 (Reuters) - <a href=\"https://laohu8.com/S/PRFX\">PainReform</a> Ltd   :</p><p>   * PAINREFORM LTD. CONFIRMS SUTURES COMPATIBILITY IN HUMAN CLINICAL TRIALS FOR PRF-110</p><p>   * PAINREFORM LTD - PRF-110 DOES NOT IMPACT MECHANICAL PROPERTIES OF PROLENE OR VICRYL SUTURES</p><p>   * PAINREFORM LTD - FINDINGS CONSISTENT WITH PHASE III BUNIONECTOMY TRIAL RESULTS</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-PainReform Confirms Sutures Compatibility In Human Clinical Trials For PRF-110</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-PainReform Confirms Sutures Compatibility In Human Clinical Trials For PRF-110\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-11 23:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Sept 11 (Reuters) - PainReform Ltd   :   * PAINREFORM LTD. CONFIRMS SUTURES COMPATIBILITY IN HUMAN CLINICAL TRIALS FOR PRF-110   * PAINREFORM LTD - PRF-110 DOES NOT IMPACT MECHANICAL PROPERTIES OF ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PRFX","symbol_name":"PainReform","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2466235957","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2466235957","pubTimestamp":1726067311,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Sept 11  - PainReform Ltd   :   * PAINREFORM LTD. CONFIRMS SUTURES COMPATIBILITY IN HUMAN CLINICAL TRIALS FOR PRF-110   * PAINREFORM LTD - PRF-110 DOES NOT IMPACT MECHANICAL PROPERTIES OF PROLENE OR VICRYL SUTURES   * PAINREFORM LTD - FINDINGS CONSISTENT WITH PHASE III BUNIONECTOMY TRIAL RESULTSSource text for Eikon:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PRFX":"PainReform","BK4585":"ETF&股票定投概念","BK4007":"制药","PRF":"Invesco FTSE RAFI US 1000 ETF","BK4588":"碎股"},"translate_title":"BRIEF-PainReform在PRF-110人体临床试验中确认缝线相容性","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRF":1,"PRFX":1},"content_text":"Sept 11 (Reuters) - PainReform Ltd   :   * PAINREFORM LTD. CONFIRMS SUTURES COMPATIBILITY IN HUMAN CLINICAL TRIALS FOR PRF-110   * PAINREFORM LTD - PRF-110 DOES NOT IMPACT MECHANICAL PROPERTIES OF PROLENE OR VICRYL SUTURES   * PAINREFORM LTD - FINDINGS CONSISTENT WITH PHASE III BUNIONECTOMY TRIAL RESULTSSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2466235957"}